{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:20Z","timestamp":1790805620625,"version":"4.1.0"},"reference-count":92,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Hedyotis diffusa Willd (HDW) is one of the most well-known herbs used in the treatment of prostate cancer. However, the potential mechanisms of its anti-tumor effects have not been fully explored. Here, we applied a network pharmacology approach to explore the potential mechanisms of HDW against prostate cancer (PCa). We obtained 14 active compounds from HDW and 295 potential PCa related targets in total to construct a network, which indicated that quercetin and ursolic acid served as the main ingredients in HDW. Mitogen-activated Protein Kinase 8 (MAPK8), Interleukin 6 (IL6), Vascular Endothelial Growth Factor A (VEGFA), Signal Transducer and Activator of Transcription 3 (STAT3), Jun Proto-Oncogene (JUN), C-X-C Motif Chemokine Ligand 8 (CXCL8), Interleukin-1 Beta (IL1B), Matrix Metalloproteinase-9 (MMP9), C-C Motif Chemokine Ligand 2 (CCL2), RELA Proto-Oncogene (RELA), and CAMP Responsive Element Binding Protein 1 (CREB1) were identified as key targets of HDW in the treatment of PCa. The protein\u2013protein interaction (PPI) cluster demonstrated that CREB1 was the seed in this cluster, indicating that CREB1 plays an important role in connecting other nodes in the PPI network. This enrichment demonstrated that HDW was highly related to translesion synthesis, unfolded protein binding, regulation of mitotic recombination, phosphatidylinositol and its kinase-mediated signaling, nucleotide excision repair, regulation of DNA recombination, and DNA topological change. The enrichment results also showed that the underlying mechanism of HDW against PCa may be due to its coordinated regulation of several cancer-related pathways, such as angiogenesis, cell differentiation, migration, apoptosis, invasion, and proliferation.<\/jats:p>","DOI":"10.3390\/biom9100591","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T11:25:57Z","timestamp":1570620357000},"page":"591","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-6766","authenticated-orcid":false,"given":"Yanan","family":"Song","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"},{"name":"Newborn Medicine, Boston Children\u2019s Hospital, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Pan","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonghua","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Prostate Cancer Trialists Collaborative Group (2000). Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials. Lancet, 355, 1491\u20131498.","DOI":"10.1016\/S0140-6736(00)02163-2"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Long, M., Smiraglia, D., and Campbell, M. (2017). The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer. Biomolecules, 7.","DOI":"10.3390\/biom7010015"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","article-title":"Radical prostatectomy versus watchful waiting in early prostate cancer","volume":"364","author":"Holmberg","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e192589","DOI":"10.1001\/jamanetworkopen.2019.2589","article-title":"Factors Associated with Use of Sipuleucel-T to Treat Patients with Advanced Prostate Cancer","volume":"2","author":"Caram","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_9","first-page":"393","article-title":"Nanocarriers for Cancer Therapy","volume":"3","author":"Vergaro","year":"2010","journal-title":"Particles"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","article-title":"PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-labeled PSMA-617","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","article-title":"225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.addr.2011.05.007","article-title":"Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells","volume":"63","author":"Vergaro","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/phar.2168","article-title":"Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer","volume":"38","author":"Nguyen","year":"2018","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(98)05180-0","article-title":"Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial","volume":"353","author":"Dearnaley","year":"1999","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.18632\/oncotarget.7245","article-title":"Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer","volume":"7","author":"Ahmadzadehfar","year":"2016","journal-title":"Oncotarget"},{"key":"ref_17","first-page":"1283","article-title":"Effect of Hedyotis diffusa Willd. extract on tumor angiogenesis","volume":"4","author":"Lin","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.3892\/ol.2016.4431","article-title":"Inhibitory effects of Hedyotis diffusa Willd. on colorectal cancer stem cells","volume":"11","author":"Sun","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_19","first-page":"942","article-title":"Chemical constituents of Hedyotis diffusa","volume":"18","author":"Si","year":"2006","journal-title":"Nat. Prod. Res. Dev."},{"key":"ref_20","first-page":"15","article-title":"Hedyotis diffusa and Panax ginseng combination: Better anticancer properties?","volume":"2","author":"Ho","year":"2018","journal-title":"Appl. Food Sci. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eujim.2018.09.008","article-title":"Hedyotis diffusa Willd. reduces migration and invasion through inhibition of TGF-\u03b2-induced EMT in colorectal cancer cells","volume":"23","author":"Chen","year":"2018","journal-title":"Eur. J. Integr. Med."},{"key":"ref_22","first-page":"1225","article-title":"Hedyotis diffusa Willd. inhibits VEGF-C-mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways","volume":"42","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2018.10.019","article-title":"Analyzing Hedyotis diffusa mechanisms of action from the genomics perspective","volume":"174","author":"Hu","year":"2019","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10496475.2018.1428919","article-title":"Antiproliferative, antimigratory, and anticlonogenic effects of Hedyotis diffusa, Panax ginseng, and their combination on colorectal cancer cell lines","volume":"24","author":"Ho","year":"2018","journal-title":"J. Herbs Spices Med. Plants"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpba.2018.07.023","article-title":"Simultaneous determination of fourteen compounds of Hedyotis diffusa Willd. extract in rats by UHPLC\u2013MS\/MS method: Application to pharmacokinetics and tissue distribution study","volume":"159","author":"Chen","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Liu, X., Wu, J., Zhang, D., Wang, K., Duan, X., and Zhang, X. (2018). A network pharmacology approach to uncover the multiple mechanisms of Hedyotis diffusa Willd. on colorectal cancer. Evid. Complement. Altern. Med., 2018.","DOI":"10.1155\/2018\/6517034"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e4389","DOI":"10.1097\/MD.0000000000004389","article-title":"Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment","volume":"95","author":"Gao","year":"2016","journal-title":"Medicine"},{"key":"ref_28","first-page":"65","article-title":"Tea and cancer prevention","volume":"4","author":"Zhang","year":"2015","journal-title":"J. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Li, S., Zhang, B., Jiang, D., Wei, Y., and Zhang, N. (2010). Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-S11-S6"},{"key":"ref_30","first-page":"110","article-title":"Traditional Chinese medicine network pharmacology: Theory, methodology and application","volume":"11","author":"Shao","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, D., Lee, W.-Y., Jung, K., Kwon, Y.S., Kim, D., Hwang, G.S., Kim, C.-E., Lee, S., and Kang, K.S. (2019). The Inhibitory Effect of Cordycepin on the Proliferation of MCF-7 Breast Cancer Cells, and its Mechanism: An Investigation Using Network Pharmacology-Based Analysis. Biomolecules, 9.","DOI":"10.3390\/biom9090414"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: The next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Li, S., Fan, T.-P., Jia, W., Lu, A., and Zhang, W. (2014). Network pharmacology in traditional Chinese medicine. Evid. Complement. Altern. Med., 2014.","DOI":"10.1155\/2014\/138460"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10408440500534362","article-title":"The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments","volume":"36","author":"Barton","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: A database of systems pharmacology for drug discovery from herbal medicines","volume":"6","author":"Ru","year":"2014","journal-title":"J. Cheminform."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D1089","DOI":"10.1093\/nar\/gks1100","article-title":"TCMID: Traditional Chinese medicine integrative database for herb molecular mechanism analysis","volume":"41","author":"Xue","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.seppur.2014.04.029","article-title":"Extraction characteristics and kinetic studies of oleanolic and ursolic acids from Hedyotis diffusa under ultrasound-assisted extraction conditions","volume":"130","author":"Wei","year":"2014","journal-title":"Sep. Purif. Technol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1248\/bpb.b110660","article-title":"Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells","volume":"35","author":"Song","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"ref_39","first-page":"69","article-title":"Determination of oleanolic acid and ursolic acid in Oldenlandia diffusa and its substitute using high performance liquid chromatography","volume":"17","author":"Liang","year":"2009","journal-title":"J. Food Drug Anal."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pinero, J., Queralt-Rosinach, N., Bravo, A., Deu-Pons, J., Bauer-Mehren, A., Baron, M., Sanz, F., and Furlong, L.I. (2015). DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes. Database, 2015.","DOI":"10.1093\/database\/bav028"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","article-title":"GeneCards: A novel functional genomics compendium with automated data mining and query reformulation support","volume":"14","author":"Rebhan","year":"1998","journal-title":"Bioinformatics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: Quality-controlled protein\u2013protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.arcmed.2011.11.003","article-title":"2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa Willd. induces apoptosis via alteration of Fas\/FasL and activation of caspase-8 in human leukemic THP-1 cells","volume":"42","author":"Wang","year":"2011","journal-title":"Arch. Med. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12272-013-0096-4","article-title":"2-Hydroxy-3-methylanthraquinone from Hedyotis diffusa Willd. induces apoptosis in human leukemic U937 cells through modulation of MAPK pathways","volume":"36","author":"Wang","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bmcl.2009.11.109","article-title":"Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa","volume":"20","author":"Xu","year":"2010","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jssc.201100780","article-title":"Characterization and identification of iridoid glucosides, flavonoids and anthraquinones in Hedyotis diffusa by high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"35","author":"Liu","year":"2012","journal-title":"J. Sep. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00216-014-8057-4","article-title":"Comprehensive two-dimensional liquid chromatography tandem diode array detector (DAD) and accurate mass QTOF-MS for the analysis of flavonoids and iridoid glycosides in Hedyotis diffusa","volume":"407","author":"Li","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27252","DOI":"10.3390\/ijms161126021","article-title":"Chemical profiles and protective effect of Hedyotis diffusa Willd. in lipopolysaccharide-induced renal inflammation mice","volume":"16","author":"Ye","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.fitote.2010.01.010","article-title":"Two new iridoid glucosides from Hedyotis diffusa","volume":"81","author":"Zhang","year":"2010","journal-title":"Fitoterapia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/hlca.201000129","article-title":"Biologically active iridoids from Hedyotis diffusa","volume":"93","author":"Ding","year":"2010","journal-title":"Helv. Chim. Acta"},{"key":"ref_55","first-page":"2016","article-title":"Inhibitive effect of Stigmasterol from Hedyotis diffusa Willd. On hepatoma cells in vitro and vivo and its influence on transplanted H22 tumor cell\u2019s multiplication cycle, apoptosis","volume":"8","author":"Zhang","year":"2008","journal-title":"Prog. Mod. Blomed."},{"key":"ref_56","first-page":"522","article-title":"Studies on the chemical constituents in Herb of Hedyotis diffusa","volume":"31","author":"Zhang","year":"2008","journal-title":"J. Chin. Med. Mater."},{"key":"ref_57","first-page":"127","article-title":"Analysis of the chemical constituents of Hedyotis diffusa","volume":"28","author":"Zhang","year":"2008","journal-title":"J. South. Med. Univ."},{"key":"ref_58","first-page":"479","article-title":"Chemical constituents of Hedyotis diffusa Willd","volume":"8","author":"Kang","year":"2007","journal-title":"J. Shenyang Pharm. Univ."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0031-9422(00)81192-9","article-title":"An anthraquinone from Hedyotis diffusa","volume":"25","author":"Ho","year":"1986","journal-title":"Phytochemistry"},{"key":"ref_60","first-page":"5","article-title":"Content determination of quercetin in Hedyotis diffusa Willd. by HPLC","volume":"1","author":"Sun","year":"2007","journal-title":"J. Guangdong Coll. Pharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14786419.2010.537275","article-title":"Qualitative analysis of the chemical constituents in Hedyotis diffusa by HPLC-TOF-MS","volume":"26","author":"Wang","year":"2012","journal-title":"Nat. Prod. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcb.21977","article-title":"Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression","volume":"106","author":"Jeong","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0014-5793(90)80053-L","article-title":"The effect of quercetin on cell cycle progression and growth of human gastric cancer cells","volume":"260","author":"Yoshida","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_64","first-page":"5754","article-title":"Inhibition of 7, 12-dimethylbenz (a) anthracene-and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin","volume":"48","author":"Verma","year":"1988","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2010.09.020","article-title":"The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-\u03baB inhibition","volume":"649","author":"Priyadarsini","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.lfs.2004.04.027","article-title":"Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells","volume":"75","author":"Hsu","year":"2004","journal-title":"Life Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2009.02.041","article-title":"Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells","volume":"281","author":"Xavier","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/07357900802672712","article-title":"Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells","volume":"27","author":"Kassi","year":"2009","journal-title":"Cancer Investig."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00109-011-0746-2","article-title":"Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice","volume":"89","author":"Shanmugam","year":"2011","journal-title":"J. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.cgt.7700931","article-title":"siRNA-based approaches in cancer therapy","volume":"13","author":"Devi","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Bateman, A. (2002). The SGS3 protein involved in PTGS finds a family. BMC Bioinform., 3.","DOI":"10.1186\/1471-2105-3-21"},{"key":"ref_72","first-page":"4705","article-title":"Genetic disruption of Ptgs-1, as well as of Ptgs-2, reduces intestinal tumorigenesis in Min mice","volume":"60","author":"Chulada","year":"2000","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12263-012-0302-x","article-title":"PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: Interaction with fatty acids in colon cancer and rectal cancer","volume":"8","author":"Habermann","year":"2013","journal-title":"Genes Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Nagao, M., Sato, Y., and Yamauchi, A. (2013). A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071126"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Li, M., Wu, X., Wang, J., and Pan, Y. (2012). Towards the identification of protein complexes and functional modules by integrating PPI network and gene expression data. BMC Bioinform., 13.","DOI":"10.1186\/1471-2105-13-109"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","article-title":"Inflammation and cancer: IL-6 and STAT3 complete the link","volume":"15","author":"Bromberg","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.molcel.2012.06.014","article-title":"Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population","volume":"47","author":"Korkaya","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"key":"ref_82","unstructured":"Xu, Z., and Hejzlar, P. (2008). MCODE, Version 2.2: An MCNP-ORIGEN Depletion Program, Massachusetts Institute of Technology\/Center for Advanced Nuclear Energy Systems."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)81752-3","article-title":"CREB1 encodes a nuclear activator, a repressor, and a cytoplasmic modulator that form a regulatory unit critical for long-term facilitation","volume":"95","author":"Bartsch","year":"1998","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1093\/nar\/gkv1528","article-title":"Integrative analysis identifies targetable CREB1\/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence","volume":"44","author":"Sunkel","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","article-title":"The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia","volume":"7","author":"Shankar","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_86","first-page":"181","article-title":"ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB","volume":"36","author":"Park","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_87","first-page":"323","article-title":"MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1","volume":"7","author":"Rao","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e2088","DOI":"10.1038\/cddis.2015.274","article-title":"c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial\u2013mesenchymal transition in bladder cancer by regulating Akt\/GSK-3\u03b2\/Snail signaling","volume":"7","author":"Xu","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"D260","DOI":"10.1093\/nar\/gkl1043","article-title":"TIGRFAMs and Genome Properties: Tools for the assignment of molecular function and biological process in prokaryotic genomes","volume":"35","author":"Selengut","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jchromb.2005.12.018","article-title":"Estimation of p-coumaric acid as metabolite of E-6-Op-coumaroyl scandoside methyl ester in rat plasma by HPLC and its application to a pharmacokinetic study","volume":"831","author":"Liu","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"ref_91","first-page":"1301","article-title":"HPLC-TOF-MS analysis of metabolites of diffusa effective extracts in rats","volume":"36","author":"Yan","year":"2011","journal-title":"China J. Chin. Mater. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jep.2010.07.014","article-title":"Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC","volume":"131","author":"Ganbold","year":"2010","journal-title":"J. Ethnopharmacol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/10\/591\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:28:35Z","timestamp":1760189315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/10\/591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["biom9100591"],"URL":"https:\/\/doi.org\/10.3390\/biom9100591","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,9]]}}}